Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02648477
Title Pembrolizumab and Doxorubicin Hydrochloride or Anti-Estrogen Therapy in Treating Patients With Triple-Negative or Hormone Receptor-Positive Metastatic Breast Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors City of Hope Medical Center
Indications

Her2-receptor negative breast cancer

triple-receptor negative breast cancer

Therapies

Letrozole + Pembrolizumab

Exemestane + Pembrolizumab

Anastrozole + Pembrolizumab

Doxorubicin + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Corona Corona California 92879 United States Details
City of Hope Medical Center Duarte California 91010 United States Details
City of Hope Antelope Valley Lancaster California 93534 United States Details
City of Hope Rancho Cucamonga Rancho Cucamonga California 91730 United States Details
City of Hope South Pasadena South Pasadena California 91030 United States Details
City of Hope West Covina West Covina California 91790 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field